Superparamagnetic Bifunctional Bisphosphonates Nanoparticles: A Potential MRI Contrast Agent for Osteoporosis Therapy and Diagnostic

A bone targeting nanosystem is reported here which combined magnetic contrast agent for Magnetic Resonance Imaging (MRI) and a therapeutic agent (bisphosphonates) into one drug delivery system. This new targeting nanoplatform consists of superparamagnetic γFe2O3 nanoparticles conjugated to 1,5-dihy...

Full description

Saved in:
Bibliographic Details
Main Authors: Y. Lalatonne, M. Monteil, H. Jouni, J. M. Serfaty, O. Sainte-Catherine, N. Lièvre, S. Kusmia, P. Weinmann, M. Lecouvey, L. Motte
Format: Article
Language:English
Published: Wiley 2010-01-01
Series:Journal of Osteoporosis
Online Access:http://dx.doi.org/10.4061/2010/747852
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832561939504431104
author Y. Lalatonne
M. Monteil
H. Jouni
J. M. Serfaty
O. Sainte-Catherine
N. Lièvre
S. Kusmia
P. Weinmann
M. Lecouvey
L. Motte
author_facet Y. Lalatonne
M. Monteil
H. Jouni
J. M. Serfaty
O. Sainte-Catherine
N. Lièvre
S. Kusmia
P. Weinmann
M. Lecouvey
L. Motte
author_sort Y. Lalatonne
collection DOAJ
description A bone targeting nanosystem is reported here which combined magnetic contrast agent for Magnetic Resonance Imaging (MRI) and a therapeutic agent (bisphosphonates) into one drug delivery system. This new targeting nanoplatform consists of superparamagnetic γFe2O3 nanoparticles conjugated to 1,5-dihydroxy-1,5,5-tris-phosphono-pentyl-phosphonic acid (di-HMBPs) molecules with a bisphosphonate function at the outer of the nanoparticle surface for bone targeting. The as-synthesized nanoparticles were evaluated as a specific MRI contrast agent by adsorption study onto hydroxyapatite and MRI measurment. The strong adsorption of the bisphosphonates nanoparticles to hydroxyapatite and their use as MRI T2∗ contrast agent were demonstrated. Cellular tests performed on human osteosarcoma cells (MG63) show that γFe2O3@di-HMBP hybrid nanomaterial has no citoxity effect in cell viability and may act as a diagnostic and therapeutic system.
format Article
id doaj-art-d3fa92bc77864f8f9e3afc6c46b950bd
institution Kabale University
issn 2042-0064
language English
publishDate 2010-01-01
publisher Wiley
record_format Article
series Journal of Osteoporosis
spelling doaj-art-d3fa92bc77864f8f9e3afc6c46b950bd2025-02-03T01:23:47ZengWileyJournal of Osteoporosis2042-00642010-01-01201010.4061/2010/747852747852Superparamagnetic Bifunctional Bisphosphonates Nanoparticles: A Potential MRI Contrast Agent for Osteoporosis Therapy and DiagnosticY. Lalatonne0M. Monteil1H. Jouni2J. M. Serfaty3O. Sainte-Catherine4N. Lièvre5S. Kusmia6P. Weinmann7M. Lecouvey8L. Motte9Laboratoire CSPBAT, C2B, FRE 3043 CNRS, Université Paris 13, 93017 Bobigny Cedex, FranceLaboratoire CSPBAT, C2B, FRE 3043 CNRS, Université Paris 13, 93017 Bobigny Cedex, FranceLaboratoire CSPBAT, C2B, FRE 3043 CNRS, Université Paris 13, 93017 Bobigny Cedex, FranceService de Radiologie, Hôpital Bichat, APHP, U 698 ISERM, Université Paris 7, 75877 Paris Cedex 18, FranceLaboratoire CSPBAT, C2B, FRE 3043 CNRS, Université Paris 13, 93017 Bobigny Cedex, FranceUPRES 3410 Biothérapies Bénéfices et Risques, Université Paris 13, 93017 Bobigny Cedex, FrancePlateforme d'IRM du Petit Animal, U 970 INSERM, Université Paris 5, 75908 Paris Cedex 10, FranceService de Médecine Nucléaire, Hôpital Avicenne, APHP, 93009 Bobigny Cedex, FranceLaboratoire CSPBAT, C2B, FRE 3043 CNRS, Université Paris 13, 93017 Bobigny Cedex, FranceLaboratoire CSPBAT, C2B, FRE 3043 CNRS, Université Paris 13, 93017 Bobigny Cedex, FranceA bone targeting nanosystem is reported here which combined magnetic contrast agent for Magnetic Resonance Imaging (MRI) and a therapeutic agent (bisphosphonates) into one drug delivery system. This new targeting nanoplatform consists of superparamagnetic γFe2O3 nanoparticles conjugated to 1,5-dihydroxy-1,5,5-tris-phosphono-pentyl-phosphonic acid (di-HMBPs) molecules with a bisphosphonate function at the outer of the nanoparticle surface for bone targeting. The as-synthesized nanoparticles were evaluated as a specific MRI contrast agent by adsorption study onto hydroxyapatite and MRI measurment. The strong adsorption of the bisphosphonates nanoparticles to hydroxyapatite and their use as MRI T2∗ contrast agent were demonstrated. Cellular tests performed on human osteosarcoma cells (MG63) show that γFe2O3@di-HMBP hybrid nanomaterial has no citoxity effect in cell viability and may act as a diagnostic and therapeutic system.http://dx.doi.org/10.4061/2010/747852
spellingShingle Y. Lalatonne
M. Monteil
H. Jouni
J. M. Serfaty
O. Sainte-Catherine
N. Lièvre
S. Kusmia
P. Weinmann
M. Lecouvey
L. Motte
Superparamagnetic Bifunctional Bisphosphonates Nanoparticles: A Potential MRI Contrast Agent for Osteoporosis Therapy and Diagnostic
Journal of Osteoporosis
title Superparamagnetic Bifunctional Bisphosphonates Nanoparticles: A Potential MRI Contrast Agent for Osteoporosis Therapy and Diagnostic
title_full Superparamagnetic Bifunctional Bisphosphonates Nanoparticles: A Potential MRI Contrast Agent for Osteoporosis Therapy and Diagnostic
title_fullStr Superparamagnetic Bifunctional Bisphosphonates Nanoparticles: A Potential MRI Contrast Agent for Osteoporosis Therapy and Diagnostic
title_full_unstemmed Superparamagnetic Bifunctional Bisphosphonates Nanoparticles: A Potential MRI Contrast Agent for Osteoporosis Therapy and Diagnostic
title_short Superparamagnetic Bifunctional Bisphosphonates Nanoparticles: A Potential MRI Contrast Agent for Osteoporosis Therapy and Diagnostic
title_sort superparamagnetic bifunctional bisphosphonates nanoparticles a potential mri contrast agent for osteoporosis therapy and diagnostic
url http://dx.doi.org/10.4061/2010/747852
work_keys_str_mv AT ylalatonne superparamagneticbifunctionalbisphosphonatesnanoparticlesapotentialmricontrastagentforosteoporosistherapyanddiagnostic
AT mmonteil superparamagneticbifunctionalbisphosphonatesnanoparticlesapotentialmricontrastagentforosteoporosistherapyanddiagnostic
AT hjouni superparamagneticbifunctionalbisphosphonatesnanoparticlesapotentialmricontrastagentforosteoporosistherapyanddiagnostic
AT jmserfaty superparamagneticbifunctionalbisphosphonatesnanoparticlesapotentialmricontrastagentforosteoporosistherapyanddiagnostic
AT osaintecatherine superparamagneticbifunctionalbisphosphonatesnanoparticlesapotentialmricontrastagentforosteoporosistherapyanddiagnostic
AT nlievre superparamagneticbifunctionalbisphosphonatesnanoparticlesapotentialmricontrastagentforosteoporosistherapyanddiagnostic
AT skusmia superparamagneticbifunctionalbisphosphonatesnanoparticlesapotentialmricontrastagentforosteoporosistherapyanddiagnostic
AT pweinmann superparamagneticbifunctionalbisphosphonatesnanoparticlesapotentialmricontrastagentforosteoporosistherapyanddiagnostic
AT mlecouvey superparamagneticbifunctionalbisphosphonatesnanoparticlesapotentialmricontrastagentforosteoporosistherapyanddiagnostic
AT lmotte superparamagneticbifunctionalbisphosphonatesnanoparticlesapotentialmricontrastagentforosteoporosistherapyanddiagnostic